Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040891862> ?p ?o ?g. }
- W3040891862 endingPage "S40" @default.
- W3040891862 startingPage "S31" @default.
- W3040891862 abstract "Because persons who identify across the transgender spectrum (PATS) are a key population in human immunodeficiency virus (HIV) yet are underreported in HIV and cardiovascular research, we aimed to characterize this population within the REPRIEVE global clinical trial (n = 7770). Acceptance of gathering gender identity was high (96%). Participation by PATS was 1.7% overall, 2.4% among natal males, 0.3% among natal females, and varied across geographic regions (from 0% in sub-Saharan Africa to 2.3% in High Income Region). Thirty percent of natal male PATS identified other than transgender. Some characteristics differed by gender. Most notably, 38% of natal male PATS receiving gender-affirming treatment had waist circumference >102 cm (compared with ≤25% in other groups). Given that PATS is a key population, HIV research should routinely report trial participation and outcomes by gender in addition to natal sex, to provide the results needed to optimize medical care to PATS." @default.
- W3040891862 created "2020-07-16" @default.
- W3040891862 creator A5001715762 @default.
- W3040891862 creator A5002243325 @default.
- W3040891862 creator A5008957693 @default.
- W3040891862 creator A5020583927 @default.
- W3040891862 creator A5024931884 @default.
- W3040891862 creator A5040544350 @default.
- W3040891862 creator A5048347860 @default.
- W3040891862 creator A5049400449 @default.
- W3040891862 creator A5052278405 @default.
- W3040891862 creator A5057932551 @default.
- W3040891862 creator A5063043469 @default.
- W3040891862 creator A5064084589 @default.
- W3040891862 creator A5064663288 @default.
- W3040891862 creator A5076913575 @default.
- W3040891862 creator A5080496049 @default.
- W3040891862 creator A5083737042 @default.
- W3040891862 creator A5084479144 @default.
- W3040891862 creator A5085250770 @default.
- W3040891862 date "2020-07-09" @default.
- W3040891862 modified "2023-10-15" @default.
- W3040891862 title "Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum" @default.
- W3040891862 cites W2115046127 @default.
- W3040891862 cites W2121833919 @default.
- W3040891862 cites W2165873164 @default.
- W3040891862 cites W2418641901 @default.
- W3040891862 cites W2431906881 @default.
- W3040891862 cites W2467090051 @default.
- W3040891862 cites W2468930881 @default.
- W3040891862 cites W2507987634 @default.
- W3040891862 cites W2604176048 @default.
- W3040891862 cites W2737493367 @default.
- W3040891862 cites W2789889936 @default.
- W3040891862 cites W2791692625 @default.
- W3040891862 cites W2795436691 @default.
- W3040891862 cites W2806665485 @default.
- W3040891862 cites W2886642434 @default.
- W3040891862 cites W2902418781 @default.
- W3040891862 cites W2905883609 @default.
- W3040891862 cites W2918271361 @default.
- W3040891862 cites W2941237325 @default.
- W3040891862 cites W2941623961 @default.
- W3040891862 cites W2942461522 @default.
- W3040891862 cites W2968200921 @default.
- W3040891862 cites W2974480863 @default.
- W3040891862 cites W2974488149 @default.
- W3040891862 cites W2975771058 @default.
- W3040891862 cites W2986165055 @default.
- W3040891862 doi "https://doi.org/10.1093/infdis/jiaa213" @default.
- W3040891862 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7347077" @default.
- W3040891862 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32645160" @default.
- W3040891862 hasPublicationYear "2020" @default.
- W3040891862 type Work @default.
- W3040891862 sameAs 3040891862 @default.
- W3040891862 citedByCount "4" @default.
- W3040891862 countsByYear W30408918622020 @default.
- W3040891862 countsByYear W30408918622021 @default.
- W3040891862 countsByYear W30408918622022 @default.
- W3040891862 crossrefType "journal-article" @default.
- W3040891862 hasAuthorship W3040891862A5001715762 @default.
- W3040891862 hasAuthorship W3040891862A5002243325 @default.
- W3040891862 hasAuthorship W3040891862A5008957693 @default.
- W3040891862 hasAuthorship W3040891862A5020583927 @default.
- W3040891862 hasAuthorship W3040891862A5024931884 @default.
- W3040891862 hasAuthorship W3040891862A5040544350 @default.
- W3040891862 hasAuthorship W3040891862A5048347860 @default.
- W3040891862 hasAuthorship W3040891862A5049400449 @default.
- W3040891862 hasAuthorship W3040891862A5052278405 @default.
- W3040891862 hasAuthorship W3040891862A5057932551 @default.
- W3040891862 hasAuthorship W3040891862A5063043469 @default.
- W3040891862 hasAuthorship W3040891862A5064084589 @default.
- W3040891862 hasAuthorship W3040891862A5064663288 @default.
- W3040891862 hasAuthorship W3040891862A5076913575 @default.
- W3040891862 hasAuthorship W3040891862A5080496049 @default.
- W3040891862 hasAuthorship W3040891862A5083737042 @default.
- W3040891862 hasAuthorship W3040891862A5084479144 @default.
- W3040891862 hasAuthorship W3040891862A5085250770 @default.
- W3040891862 hasBestOaLocation W30408918621 @default.
- W3040891862 hasConcept C11171543 @default.
- W3040891862 hasConcept C126322002 @default.
- W3040891862 hasConcept C144024400 @default.
- W3040891862 hasConcept C149923435 @default.
- W3040891862 hasConcept C15744967 @default.
- W3040891862 hasConcept C2776193436 @default.
- W3040891862 hasConcept C2776939746 @default.
- W3040891862 hasConcept C2776983459 @default.
- W3040891862 hasConcept C2779671885 @default.
- W3040891862 hasConcept C2908647359 @default.
- W3040891862 hasConcept C2991839931 @default.
- W3040891862 hasConcept C3013748606 @default.
- W3040891862 hasConcept C3020302352 @default.
- W3040891862 hasConcept C511355011 @default.
- W3040891862 hasConcept C512399662 @default.
- W3040891862 hasConcept C535046627 @default.
- W3040891862 hasConcept C71924100 @default.
- W3040891862 hasConcept C74909509 @default.
- W3040891862 hasConcept C77805123 @default.